Patient-reported outcome measures in phase III trials of LY2963016 insulin glargine and reference insulin glargine products: ELEMENT 1 and ELEMENT 2
Authors:
Perez-Nieves M, K Pollom R, Duan R, Kalirai S, Delozier A, Kaushik P and Ilag L
Publication type:
Journal article
Publication name:
Generics and Biosimilars Initiative Journal
Citation:
Perez-Nieves M, K Pollom R, Duan R, Kalirai S, Delozier A, Kaushik P and Ilag L. Patient-reported outcome measures in phase III trials of LY2963016 insulin glargine and reference insulin glargine products: ELEMENT 1 and ELEMENT 2. GaBI Journal. 2018; 7(2):56-62.
